Sandford D Smith - Net Worth and Insider Trading
Sandford D Smith Net Worth
The estimated net worth of Sandford D Smith is at least $684,015 dollars as of 2024-11-13. Sandford D Smith is the Director of Cytokinetics Inc and owns about 12,170 shares of Cytokinetics Inc (CYTK) stock worth over $684,015. Sandford D Smith is also the Director of Aegerion Pharmaceuticals Inc and owns about 0 shares of Aegerion Pharmaceuticals Inc (AEGR) stock worth over $0. Details can be seen in Sandford D Smith's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sandford D Smith has not made any transactions after 2022-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sandford D Smith
Sandford D Smith Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandford D Smith owns 8 companies in total, including Akcea Therapeutics Inc (AKCA) , Cytokinetics Inc (CYTK) , and Seneca Biopharma Inc (SNCA) among others .
Click here to see the complete history of Sandford D Smith’s form 4 insider trades.
Insider Ownership Summary of Sandford D Smith
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKCA | Akcea Therapeutics Inc | 2020-10-12 | director |
| CYTK | Cytokinetics Inc | 2022-09-02 | director |
| SNCA | Seneca Biopharma Inc | 2019-07-01 | director |
 | | 2014-08-08 | director |
| | 2017-01-27 | director |
| | 2016-11-29 | director |
| | 2008-07-10 | director |
| | 2014-05-08 | director |
Sandford D Smith Latest Holdings Summary
Sandford D Smith currently owns a total of 2 stocks. Among these stocks, Sandford D Smith owns 12,170 shares of Cytokinetics Inc (CYTK) as of September 2, 2022, with a value of $684,015 and a weighting of 100%. Sandford D Smith also owns 0 shares of Aegerion Pharmaceuticals Inc (AEGR) as of October 29, 2013, with a value of $0 and a weighting of 0%.
Latest Holdings of Sandford D Smith
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2022-09-02 | 12,170 | 56.21 | 684,015 |
| AEGR | Aegerion Pharmaceuticals Inc | 2013-10-29 | 0 | 1.97 | 0 |
Holding Weightings of Sandford D Smith
Sandford D Smith Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandford D Smith has made a total of 16 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Cytokinetics Inc is the sale of 11,369 shares on September 2, 2022, which brought Sandford D Smith around $613,585.
According to the SEC Form 4 filings, Sandford D Smith has made a total of 0 transactions in Aegerion Pharmaceuticals Inc (AEGR) over the past 5 years. The most-recent trade in Aegerion Pharmaceuticals Inc is the sale of 2,502 shares on October 29, 2013, which brought Sandford D Smith around $237,690.
Insider Trading History of Sandford D Smith
- 1
Sandford D Smith Trading Performance
Sandford D Smith Ownership Network
Ownership Network List of Sandford D Smith
Ownership Network Relation of Sandford D Smith
Sandford D Smith Owned Company Details
What does Akcea Therapeutics Inc do?
Who are the key executives at Akcea Therapeutics Inc?
Sandford D Smith is the director of Akcea Therapeutics Inc. Other key executives at Akcea Therapeutics Inc include director & Chief Executive Officer Damien Mcdevitt , Chief Medical Officer William T. Andrews , and Chief Financial Officer Michael Dennis Price .
Akcea Therapeutics Inc (AKCA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Akcea Therapeutics Inc (AKCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akcea Therapeutics Inc (AKCA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Akcea Therapeutics Inc (AKCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akcea Therapeutics Inc Insider Transactions
Sandford D Smith Mailing Address
Above is the net worth, insider trading, and ownership report for Sandford D Smith. You might contact Sandford D Smith via mailing address: C/o Ariad Pharmaceuticals Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
